Net Cash Provided by (Used in) Financing Activities of AXIM BIOTECHNOLOGIES, INC. from 31 Mar 2011 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary: AXIM BIOTECHNOLOGIES, INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2011 to 31 Mar 2024.
AXIM BIOTECHNOLOGIES, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $195,599, a 32% increase year-over-year.
AXIM BIOTECHNOLOGIES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,139,675, a 31% decline from 2022.
AXIM BIOTECHNOLOGIES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1,647,355, a 35% decline from 2021.
AXIM BIOTECHNOLOGIES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $2,533,042, a 20% decline from 2020.
Source SEC data: View on sec.gov

Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)

Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Net Cash Provided by (Used in) Financing Activities, Annual (USD)

Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$195,599	+$47,380	+32%	01 Jan 2024	31 Mar 2024	10-Q/A	22 May 2024	2024	Q1
Q1 2023	$148,219	-$510,578	-78%	01 Jan 2023	31 Mar 2023	10-Q/A	22 May 2024	2024	Q1
Q1 2022	$658,797	+$81,664	+14%	01 Jan 2022	31 Mar 2022	10-Q	22 May 2023	2023	Q1
Q1 2021	$577,133	-$351,028	-38%	01 Jan 2021	31 Mar 2021	10-Q	23 May 2022	2022	Q1
Q1 2020	$928,161	-$657,151	-41%	01 Jan 2020	31 Mar 2020	10-Q/A	02 Jun 2021	2021	Q1
Q1 2019	$1,585,312	+$1,754,200		01 Jan 2019	31 Mar 2019	10-Q/A	02 Jul 2020	2020	Q1
Q1 2018	$168,888	-$668,888	-134%	01 Jan 2018	31 Mar 2018	10-Q	15 May 2019	2019	Q1
Q1 2017	$500,000	+$270,000	+117%	01 Jan 2017	31 Mar 2017	10-Q/A	18 May 2018	2018	Q1
Q1 2016	$230,000	+$230,000		01 Jan 2016	31 Mar 2016	10-Q/A	14 Sep 2017	2017	Q1
Q1 2015	$0	+$127		01 Jan 2015	31 Mar 2015	10-Q/A	26 May 2016	2016	Q1
Q1 2014	$127^*			01 Jan 2014	31 Mar 2014	10-Q	13 May 2015	2015	Q1
Q1 2012	$9,510	+$9,510		01 Jan 2012	31 Mar 2012	10-Q	15 May 2013	2013	Q1
Q1 2011	$0			01 Jan 2011	31 Mar 2011	10-Q	17 May 2012	2012	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$1,139,675	-$507,680	-31%	01 Jan 2023	31 Dec 2023	10-K	16 Apr 2024	2023	FY
2022	$1,647,355	-$885,687	-35%	01 Jan 2022	31 Dec 2022	10-K	16 Apr 2024	2023	FY
2021	$2,533,042	-$618,228	-20%	01 Jan 2021	31 Dec 2021	10-K	17 Apr 2023	2022	FY
2020	$3,151,270	-$245,529	-7.2%	01 Jan 2020	31 Dec 2020	10-K/A	19 Apr 2022	2021	FY
2019	$3,396,799	-$1,196,254	-26%	01 Jan 2019	31 Dec 2019	10-K/A	26 Apr 2021	2020	FY
2018	$4,593,053	+$166,600	+3.8%	01 Jan 2018	31 Dec 2018	10-K/A	20 May 2020	2019	FY
2017	$4,426,453	+$2,553,136	+136%	01 Jan 2017	31 Dec 2017	10-K	08 Apr 2019	2018	FY
2016	$1,873,317	+$844,317	+82%	01 Jan 2016	31 Dec 2016	10-K	15 Mar 2018	2017	FY
2015	$1,029,000	+$29,000	+2.9%	01 Jan 2015	31 Dec 2015	10-K/A	14 Sep 2017	2016	FY
2014	$1,000,000	+$985,983	+7034%	01 Jan 2014	31 Dec 2014	10-K/A	18 Apr 2016	2015	FY
2013	$14,017	-$60,868	-81%	01 Jan 2013	31 Dec 2013	10-K	14 Apr 2015	2014	FY
2012	$74,885	+$55,785	+292%	01 Jan 2012	31 Dec 2012	10-K	15 Apr 2013	2012	FY
2011	$19,100			01 Jan 2011	31 Dec 2011	10-K	15 Apr 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.